Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole ointment for non-healing pilonidal disease
ACTRN12618002038279Phase 2Not yet recruiting
- Sponsor
- David Lubowski
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of metronidazole in pilonidal cyst and Chronic wound (3 arms), sponsored by David Lubowski. Primary endpoints: Proportion of patients healed at 6 weeks and Safety. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
metronidazole
03
Conditions
pilonidal cystChronic wound
Beyond the preview
Go deeper on ACTRN12618002038279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618002038279.